Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.5 to v3.6.6. This reflects a version update to the study details page on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-08-29T21:56:35.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    An updated page revision is shown: 'Revision: v3.6.5' replaces 'Revision: v3.6.4', reflecting a newer version of the page/templating for the study details.
    Difference
    0.1%
    Check dated 2026-08-08T17:34:39.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.3 to v3.6.4, indicating a newer build of the study details page. This change does not modify study details or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-07-25T10:22:03.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a new site version. The change appears to be a backend/software update without altering study content or user actions.
    Difference
    0.1%
    Check dated 2026-07-03T22:36:04.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page's revision identifier was updated from v3.6.0 to v3.6.2, signaling a new version of the page or its underlying system.
    Difference
    0.1%
    Check dated 2026-06-26T20:53:29.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    New help and join-related sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the recruitment status now shows 'No longer looking for participants'. The 'Intervention/Treatment' label was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T11:37:26.000Z thumbnail image

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.